245 related articles for article (PubMed ID: 19671698)
1. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus.
Prabu A; Patel K; Yee CS; Nightingale P; Situnayake RD; Thickett DR; Townend JN; Gordon C
Rheumatology (Oxford); 2009 Dec; 48(12):1506-11. PubMed ID: 19671698
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension].
Luo RQ; Lei YX; Zhang X; Liang F
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1860-3. PubMed ID: 18971190
[TBL] [Abstract][Full Text] [Related]
4. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
10. Determinants of pulmonary arterial hypertension in scleroderma.
Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in systemic lupus erythematosus.
Simonson JS; Schiller NB; Petri M; Hellmann DB
J Rheumatol; 1989 Jul; 16(7):918-25. PubMed ID: 2769664
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
13. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
14. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis.
Phung S; Strange G; Chung LP; Leong J; Dalton B; Roddy J; Deague J; Playford D; Musk M; Gabbay E
Intern Med J; 2009 Oct; 39(10):682-91. PubMed ID: 19220532
[TBL] [Abstract][Full Text] [Related]
18. High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
Kim KJ; Baek IW; Park YJ; Yoon CH; Kim WU; Cho CS
Int J Rheum Dis; 2015 Jun; 18(5):524-32. PubMed ID: 24428867
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
[TBL] [Abstract][Full Text] [Related]
20. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]